Nantahala Capital Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.9M Buy
6,122,403
+75,000
+1% +$629K 3.49% 9
2025
Q4
$45M Buy
6,047,403
+236,741
+4% +$1.7M 2.68% 14
2025
Q3
$38.9M Buy
5,810,662
+529,820
+10% +$3.68M 2.4% 17
2025
Q2
$35M Buy
5,280,842
+1,155,192
+28% +$8.19M 2.47% 13
2025
Q1
$37.7M Buy
4,125,650
+98,841
+2% +$987K 3.12% 12
2024
Q4
$42.3M Sell
4,026,809
-324,061
-7% -$3.83M 2.96% 11
2024
Q3
$52M Sell
4,350,870
-987,444
-18% -$8.54M 4.37% 7
2024
Q2
$30.7M Sell
5,338,314
-467,698
-8% -$2.57M 3.08% 10
2024
Q1
$30.2M Sell
5,806,012
-171,459
-3% -$838K 2.96% 12
2023
Q4
$31.5M Sell
5,977,471
-41,061
-0.7% -$162K 3.15% 9
2023
Q3
$19.9M Buy
6,018,532
+400,906
+7% +$1.41M 2.52% 14
2023
Q2
$16.2M Buy
5,617,626
+444,157
+9% +$852K 1.97% 13
2023
Q1
$5.54M Buy
5,173,469
+2,004,895
+63% +$3.84M 0.53% 47
2022
Q4
$8.27M Buy
3,168,574
+2,789,735
+736% +$12.2M 0.75% 40
2022
Q3
$2.65M Buy
+378,839
New +$2.97M 0.26% 68

Other funds holding BVS